Literature DB >> 33939190

Evaluating the feasibility and acceptability of a mobile-based health technology for smoking cessation: Mobile Anxiety Sensitivity Program.

Lorra Garey1, Emily T Hébert2, Nubia A Mayorga1, JeanFelix Chavez1, Justin M Shepherd1, Michael S Businelle3, Michael J Zvolensky1,4,5.   

Abstract

OBJECTIVES: Cigarette smoking is the leading preventable cause of death and disability. Although most US smokers want to quit, more than 95% of cessation attempts end in relapse within 6 months. To improve cessation outcomes, research has turned to targetable mechanisms, such as anxiety sensitivity (AS), which maintain smoking behaviour, impede cessation success, and can be effectively targeted in the context of psychosocial interventions. Although integrated treatment programmes that address AS reduction in the context of smoking cessation have demonstrated promising results, presently, no mobile, technology-based integrated treatment exists to expressly address smoking and AS. The current study evaluated the initial feasibility and acceptability of a mobile smoking cessation intervention, Mobile Anxiety Sensitivity Program for smoking (MASP).
METHODS: Participants were 15 daily adult combustible cigarette smokers (females n = 6, Mage  = 46.5 years, SD = 13.3) who completed a 6-week total intervention period (baseline visit, 2 weeks pre-quit, 4 weeks post-quit, follow-up visit).
RESULTS: Most participants (N = 12) completed the full 6-week intervention, and participant engagement with MASP was high. Participants reported that MASP was acceptable. Biochemical verification of smoking abstinence indicated 25% of smokers were abstinent for at least 24 hr prior to the in-person 4 weeks post-quit follow-up visit.
CONCLUSIONS: Findings indicated that MASP has the potential to provide effective assistance to those wanting to quit cigarettes. PRACTITIONER POINTS: Mobile-based smoking cessation interventions may be a promising treatment option, particularly for those of lower socio-economic status. Targeting AS in the context of a mobile-based smoking cessation app may be a viable way to improve smoking cessation success and treatment outcome. Due to the pilot nature of this study, there was no control group. Thus, comparative conclusions and generalizability based on the current study must be made with caution.
© 2021 The British Psychological Society.

Entities:  

Keywords:  Anxiety Sensitivity; Mobile Health; Smoking Cessation; Tobacco

Mesh:

Year:  2021        PMID: 33939190      PMCID: PMC8563508          DOI: 10.1111/bjc.12294

Source DB:  PubMed          Journal:  Br J Clin Psychol        ISSN: 0144-6657


  54 in total

Review 1.  Shape of the relapse curve and long-term abstinence among untreated smokers.

Authors:  John R Hughes; Josue Keely; Shelly Naud
Journal:  Addiction       Date:  2004-01       Impact factor: 6.526

2.  Incremental validity of anxiety sensitivity in terms of motivation to quit, reasons for quitting, and barriers to quitting among community-recruited daily smokers.

Authors:  Michael J Zvolensky; Anka A Vujanovic; Marcel O Bonn Miller; Amit Bernstein; Andrew R Yartz; Kristin L Gregor; Alison C McLeish; Erin C Marshall; Laura E Gibson
Journal:  Nicotine Tob Res       Date:  2007-09       Impact factor: 4.244

Review 3.  A review of computer and Internet-based interventions for smoking behavior.

Authors:  Scott T Walters; Jo Anne Wright; Ross Shegog
Journal:  Addict Behav       Date:  2005-06-13       Impact factor: 3.913

4.  Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence.

Authors:  Kenneth A Perkins; Joshua L Karelitz; Nancy C Jao
Journal:  Nicotine Tob Res       Date:  2012-09-18       Impact factor: 4.244

5.  Refinement of a brief anxiety sensitivity reduction intervention.

Authors:  Meghan E Keough; Norman B Schmidt
Journal:  J Consult Clin Psychol       Date:  2012-04-02

6.  The effects of an anxiety sensitivity intervention on insomnia symptoms.

Authors:  Nicole A Short; Nicholas P Allan; Amanda M Raines; Norman B Schmidt
Journal:  Sleep Med       Date:  2014-11-25       Impact factor: 3.492

7.  Anxiety sensitivity and perceived control over anxiety-related events: associations with smoking outcome expectancies and perceived cessation barriers among daily smokers.

Authors:  Kristin L Gregor; Michael J Zvolensky; Alison C McLeish; Amit Bernstein; Sandra Morissette
Journal:  Nicotine Tob Res       Date:  2008-04       Impact factor: 4.244

8.  Vital Signs: Racial Disparities in Age-Specific Mortality Among Blacks or African Americans - United States, 1999-2015.

Authors:  Timothy J Cunningham; Janet B Croft; Yong Liu; Hua Lu; Paul I Eke; Wayne H Giles
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-05-05       Impact factor: 17.586

Review 9.  Effectiveness of Mobile Apps for Smoking Cessation: A Review.

Authors:  Kabindra Regmi; Norhayati Kassim; Norhayati Ahmad; Nik A Tuah
Journal:  Tob Prev Cessat       Date:  2017-04-12

10.  Current Cigarette Smoking Among Adults - United States, 2016.

Authors:  Ahmed Jamal; Elyse Phillips; Andrea S Gentzke; David M Homa; Stephen D Babb; Brian A King; Linda J Neff
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-19       Impact factor: 17.586

View more
  3 in total

Review 1.  Interoceptive anxiety-related processes: Importance for understanding COVID-19 and future pandemic mental health and addictive behaviors and their comorbidity.

Authors:  Michael J Zvolensky; Brooke Y Kauffman; Lorra Garey; Andres G Viana; Cameron T Matoska
Journal:  Behav Res Ther       Date:  2022-06-18

2.  An Integrated mHealth App for Smoking Cessation in Black Smokers With Anxiety: Protocol for a Randomized Controlled Trial.

Authors:  Michael S Businelle; Lorra Garey; Matthew W Gallagher; Emily T Hébert; Anka Vujanovic; Adam Alexander; Krista Kezbers; Cameron Matoska; Jillian Robison; Audrey Montgomery; Michael J Zvolensky
Journal:  JMIR Res Protoc       Date:  2022-05-30

3.  Feasibility and acceptability of experience sampling among LGBTQ+ young people with self-harmful thoughts and behaviours.

Authors:  A J Williams; Jon Arcelus; Ellen Townsend; Maria Michail
Journal:  Front Psychiatry       Date:  2022-08-17       Impact factor: 5.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.